Answers are grounded in this paper and cite their sources.
Intravitreal injections with vascular endothelial growth factor inhibitors constitute the most prevalent ophthalmic procedure in developed countries. Historically, there has been steady growth in the number of treatments performed of this kind, and projection studies estimate further growth in such treatments in the future. We provide a practical approach to intravitreal injections and discuss important aspects relating to the setting, the patient, the procedure, and the information given to the patient.
No takes yet. Share an insight, caveat, or question.
Petri et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: